Article

Correlation of URGCP Gene Expression in Neurotrophic Tyrosin Kinase 1,2,3 and MAPK Signal Transduction Pathways as a New Approach in Sarcomas

2025-07-28

Abstract excerpt

<title>Abstract</title> <p>Sarcoma is a heterogeneous malignant cancer of mesenchymal origin, and approximately 80% is soft tissue sarcoma (STS), which accounts for 1% of all malignant cancers. NTRKs, one of the gene fusions, are important factors involved in the development and differentiation of nerve cells. The MAPK signalling pathway can lead to processes such as migration, invasion and metastasis of tumour c...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 0c122302-3dd6-5ac5-9c4a-1939650fc94a
DOI: 10.21203/rs.3.rs-7009634/v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Correlation of URGCP Gene Expression in Neurotrophic Tyrosin Kinase 1,2,3 and MAPK Signal Transduction Pathways as a New Approach in SarcomasDOI 10.21203/rs.3.rs-7009634/v1Read

NTRK1-3 Fusions in Sarcomas: Prevalence, Significance, and Clinical Implications – A Systematic ReviewSemantic proximity Read

Current management of neurotrophic receptor tyrosine kinase fusion-positive sarcoma: an updated reviewSemantic proximity Read

NTRK Fusions in Sarcomas: Diagnostic Challenges and Clinical AspectsSemantic proximity Read

A review of NTRK fusions in cancerSemantic proximity Read

Prevalence of neurotrophic tropomyosin receptor kinase ( NTRK ) fusion gene positivity in patients with solid tumors in JapanSemantic proximity Read

The Next Frontier in Sarcoma: Molecular Pathways and Associated Targeted TherapiesSemantic proximity Read

Diagnosis and management of tropomyosin receptor kinase (TRK) fusion sarcomas: expert recommendations from the World Sarcoma NetworkSemantic proximity Read

Identification of Dual STRN-NTRK2 Rearrangements in a High Grade Sarcoma, With Good Clinical Response to First-line Larotrectinib TherapySemantic proximity Read

BRAF mutations and concurrent alterations in patients with soft tissue sarcoma.Semantic proximity Read

NTRK Fusions in a Sarcomas Series: Pathology, Molecular and Clinical AspectsSemantic proximity Read

Identification of dual STRN-NTRK2 rearrangements in a high grade sarcoma, with good clinical response to first-line larotrectinib therapySemantic proximity Read

The First Case Treated with Larotrectinib of a Novel TMTC2-NTRK3 Fusion Undifferentiated High-Grade Pleomorphic Sarcoma of the ChestSemantic proximity Read